Aristeidis Roubanis

Aristeidis Roubanis

Auto-generated profile, based on publicly available information

Aristeidis Roubanis

Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in Science Advances
Verified
Journal Article
Open access
MHMorgane Hilaire
Morgane Hilaire
AMAngélina Mimoun
Angélina Mimoun
LCLéonie Cagnet
Léonie Cagnet
RVRémy Villette
Rémy Villette
ARAristeidis Roubanis
Aristeidis Roubanis
BSBenoît L. Salomon
Benoît L. Salomon
Foxp3 + regulatory T cells (T regs ) reside in both lymphoid and nonlymphoid organs, where they play a crucial role in immune tolerance and tissue homeostasis. In mice, T regs begin colonizing these tissues shortly after birth, contributing to long-term immune response regulation therein. However, the kinetics of T reg generation across different tissues remains unclear. Here, we investigate T reg ontogeny from birth to adulthood in various tissues. In lymphoid organs, the adult T reg pool is continuously replenished with cells generated at different ages. In contrast, the skin retains a large fraction of T regs that colonize the tissue during the neonatal period, with minimal turnover in adulthood. The liver, lungs, and colon exhibit intermediate T reg renewal dynamics. Notably, neonatal T regs that persist into adulthood display a more activated phenotype and express markers associated with tissue-resident T regs and type 2 immunity. Our findings reveal tissue-specific differences in T reg generation kinetics and highlight a major phenotypic shift between neonatal and adult-derived T regs .

10 August 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
FHFeng He
Feng He
AMAndrea Martí-Sarrias
Andrea Martí-Sarrias
HGHeval Atas Guvenilir
Heval Atas Guvenilir
RSRenata Baptista Vieira de Sá
Renata Baptista Vieira de Sá
ASAdithya Sridhar
Adithya Sridhar
RKRejko Krüger
Rejko Krüger
Neurological complications are among typical clinical manifestations, both during the acute phase of SARS-CoV-2 infection and long-term post-acute COVID-19 sequelae, i.e., Long COVID. A growing body of evidence connects SARS-CoV-2 infection to systemic inflammation, peripheral immune dysregulation, functional alteration of the blood–brain barrier (BBB), neuroinflammatory processes, mitochondrial dysfunction and pathological protein aggregation, all of which are central to the pathogenesis of major neurodegenerative diseases. In this review, we discuss the converging shared underlying molecular mechanisms that link the ‘acute’ SARS-CoV-2 infection that often only lasts for days and ‘chronic’ neurodegenerative diseases that often take decades to develop. We further review human induced pluripotent stem cells (iPSCs)-derived brain organoid and BBB models for Parkinson’s disease (PD) and Alzheimer’s disease (AD) as well as artificial intelligence (AI)-facilitated knowledge graph methods that are used to hypothesize and validate the potential mechanistic links. We propose that besides the established links between viral infections and neurodegenerative or neuroinflammatory conditions, such as Epstein-Barr virus (EBV) in multiple sclerosis or herpes zoster in AD, SARS-CoV-2 infection might be another important factor driving the future burden of the most common neurodegenerative diseases. Graphical Abstract Schematic illustrating the potential link between the progression from SARS-CoV-2 infection and immune dysregulation to the development of Long COVID and eventually the subsequent onset of major neurodegenerative diseases (e.g., Parkinson's disease and Alzheimer's disease).